Get started
Author

Giorgio Mauri

Observed name: G. Mauri
ORCID: 0009-0008-7689-6460
Observed ORCID: 0009-0008-7689-6460
OpenAlex ID: A5089730135
TNF-Related Apoptosis-Inducing Ligand (TRAIL)–Armed Exosomes Deliver Proapoptotic Signals to Tumor Site
2016 · Licia Rivoltini, Claudia Chiodoni, et al. · Clinical Cancer Research · 195
PDF
Mast Cell Targeting Hampers Prostate Adenocarcinoma Development but Promotes the Occurrence of Highly Malignant Neuroendocrine Cancers
2011 · Paola Pittoni, Claudio Tripodo, et al. · Cancer Research · 146
PDF
Antitumor effects of the multi-target tyrosine kinase inhibitor cabozantinib: a comprehensive review of the preclinical evidence
2021 · Matteo Santoni, Roberto Iacovelli, et al. · Expert Review of Anticancer Therapy · 44
Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers
2015 · Giorgio Mauri, Elena Jachetti, et al. · Oncotarget · 12
PDF
Ultrasound-guided intra-tumor injection of combined immunotherapy cures mice from orthotopic prostate cancer
2013 · Giorgio Mauri, Claudia Chiodoni, et al. · Cancer Immunology Immunotherapy · 6
Association of pre- and postoperative delirium with functional status at discharge after hip fracture: findings from the Gruppo Italiano di Ortogeriatria (GIOG 2.0) study
2026 · Maria Cristina Ferrara, Francesca Remelli, et al. · European Geriatric Medicine · 2
PDF
Abstract PS3-07-08: Sustained Ovarian Function Suppression with Triptorelin in Premenopausal HR+ HER2− Breast Cancer: Results from the Second Interim Analysis of the ROSE Study
2026 · A. Fabi, G. V. Bianchi, et al. · Clinical Cancer Research
Abstract P1-12-11: Individualized Breast Cancer Treatment Strategies: Real-World Insights from the ROSE Study
2025 · Alessandra Fabi, Luisa Carbognin, et al. · Clinical Cancer Research
Survival, treatment duration and costs of patients with prostate cancer treated with triptorelin in Italy: a study of administrative databases
2024 · Orazio Caffo, Gaetano Facchini, et al. · Global & Regional Health Technology Assessment
Supplementary Materials and Methods from TNF-Related Apoptosis-Inducing Ligand (TRAIL)–Armed Exosomes Deliver Proapoptotic Signals to Tumor Site
2023 · Licia Rivoltini, Claudia Chiodoni, et al.
Supplementary Figure S2 from TNF-Related Apoptosis-Inducing Ligand (TRAIL)–Armed Exosomes Deliver Proapoptotic Signals to Tumor Site
2023 · Licia Rivoltini, Claudia Chiodoni, et al.
Supplementary Figure S4 from TNF-Related Apoptosis-Inducing Ligand (TRAIL)–Armed Exosomes Deliver Proapoptotic Signals to Tumor Site
2023 · Licia Rivoltini, Claudia Chiodoni, et al.
Supplementary Figure S3 from TNF-Related Apoptosis-Inducing Ligand (TRAIL)–Armed Exosomes Deliver Proapoptotic Signals to Tumor Site
2023 · Licia Rivoltini, Claudia Chiodoni, et al.
Supplementary Figure S1 from TNF-Related Apoptosis-Inducing Ligand (TRAIL)–Armed Exosomes Deliver Proapoptotic Signals to Tumor Site
2023 · Licia Rivoltini, Claudia Chiodoni, et al.
Supplementary Figure Legends from TNF-Related Apoptosis-Inducing Ligand (TRAIL)–Armed Exosomes Deliver Proapoptotic Signals to Tumor Site
2023 · Licia Rivoltini, Claudia Chiodoni, et al.
Data from TNF-Related Apoptosis-Inducing Ligand (TRAIL)–Armed Exosomes Deliver Proapoptotic Signals to Tumor Site
2023 · Licia Rivoltini, Claudia Chiodoni, et al.
Supplementary Figure S4 from TNF-Related Apoptosis-Inducing Ligand (TRAIL)–Armed Exosomes Deliver Proapoptotic Signals to Tumor Site
2023 · Licia Rivoltini, Claudia Chiodoni, et al.
PDF
Supplementary Methods, Figures 1-6 from Mast Cell Targeting Hampers Prostate Adenocarcinoma Development but Promotes the Occurrence of Highly Malignant Neuroendocrine Cancers
2023 · Paola Pittoni, Claudio Tripodo, et al.
Data from Mast Cell Targeting Hampers Prostate Adenocarcinoma Development but Promotes the Occurrence of Highly Malignant Neuroendocrine Cancers
2023 · Paola Pittoni, Claudio Tripodo, et al.
Data from Mast Cell Targeting Hampers Prostate Adenocarcinoma Development but Promotes the Occurrence of Highly Malignant Neuroendocrine Cancers
2023 · Paola Pittoni, Claudio Tripodo, et al.
Works count: 20
Citation count: 405
H-index: 5
I10-index: 4
Year
Topic
Type